BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 25449762)

  • 1. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephrogenic syndrome of inappropriate antidiuresis].
    Nawal B; Izzedine H; Haddiya I; Bentata Y
    Pan Afr Med J; 2019; 32():210. PubMed ID: 31312322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital nephrogenic diabetes insipidus].
    Morin D; Delenne AL; Kervran A
    Arch Pediatr; 2005 Jan; 12(1):59-66. PubMed ID: 15653057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
    Rosenthal SM; Feldman BJ; Vargas GA; Gitelman SE
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():66-70. PubMed ID: 17261972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.
    Ranieri M; Tamma G; Pellegrino T; Vezzi V; Ambrosio C; Grò C; Di Mise A; Costa T; Valenti G; Cotecchia S
    Pflugers Arch; 2019 Oct; 471(10):1291-1304. PubMed ID: 31486901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
    Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
    PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrogenic diabetes insipidus].
    Bichet DG
    Nephrol Ther; 2006 Nov; 2(6):387-404. PubMed ID: 17081961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
    Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
    Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
    Rochdi MD; Vargas GA; Carpentier E; Oligny-Longpré G; Chen S; Kovoor A; Gitelman SE; Rosenthal SM; von Zastrow M; Bouvier M
    Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
    Gitelman SE; Feldman BJ; Rosenthal SM
    Am J Med; 2006 Jul; 119(7 Suppl 1):S54-8. PubMed ID: 16843086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasopressin-aquaporin-2 pathway syndromes.
    Valenti G; Tamma G
    Handb Clin Neurol; 2021; 181():249-259. PubMed ID: 34238461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of nephrogenic diabetes insipidus.
    Hureaux M; Vargas-Poussou R
    Mol Cell Endocrinol; 2023 Jan; 560():111825. PubMed ID: 36460218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of responsiveness to 1-desamino-D arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside.
    Vandergheynst F; Pradier O; Beukinga I; Kornreich A; Vassart G; Decaux G
    Eur J Clin Invest; 2012 Mar; 42(3):254-9. PubMed ID: 21834801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.